Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04857645
What this trial is testing

ASTX727 and Donor Lymphocyte Infusions After Allogenic Stem Cell Transplantation in Very High Risk MDS or AML Patients

Who this might be right for
MDSAML
Groupe Francophone des Myelodysplasies 57
Not applicableLooking for participantsNCT04249830
What this trial is testing

Stem Cell Transplant From Donors After Alpha Beta Cell Depletion in Children and Young Adults

Who this might be right for
Hematologic Diseases
Alice Bertaina 204
Testing effectiveness (Phase 2)Ended earlyNCT00937053
What this trial is testing

Maintaining a Higher Level of Haemoglobin: Effect on the White Cells After Bone Marrow Transplantation in Children.

Who this might be right for
Neutropenia
St. Justine's Hospital 6
Early research (Phase 1)WithdrawnNCT00524953
What this trial is testing

Phase I Clinical Trial to Assess Safety of UV Phototherapy for the Prevention of GVHD Post Allogeneic SCT

Who this might be right for
Allogeneic Transplantation (Non T-cell Depleted)
Hadassah Medical Organization
Testing effectiveness (Phase 2)Active Not RecruitingNCT05354557
What this trial is testing

Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 16
Testing effectiveness (Phase 2)WithdrawnNCT01047072
What this trial is testing

Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis

Who this might be right for
Systemic Scleroderma
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Early research (Phase 1)WithdrawnNCT03902067
What this trial is testing

UC-MSC Transplantation for Left Ventricular Dysfunction After AMI

Who this might be right for
Left Ventricular DysfunctionAcute Myocardial Infarction
Shanghai Life Science & Technology
Testing effectiveness (Phase 2)Study completedNCT05148299
What this trial is testing

Pegcetacoplan for Patients With Transplant-associated Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation

Who this might be right for
Transplant-Associated Thrombotic Microangiopathy
Swedish Orphan Biovitrum 12
Testing effectiveness (Phase 2)UnknownNCT01759732
What this trial is testing

Haploidentical Stem Cell Transplantation for Children With Acquired Severe Aplastic Anemia

Who this might be right for
Acquired Aplastic Anemia
Asan Medical Center 10
Large-scale testing (Phase 3)Study completedNCT03901963
What this trial is testing

Daratumumab Plus Lenalidomide Versus Lenalidomide Alone as Maintenance Treatment in Participants With Newly Diagnosed Multiple Myeloma Who Are Minimal Residual Disease Positive After Frontline Autologous Stem Cell Transplant

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC 200
Testing effectiveness (Phase 2)Study completedNCT00775632
What this trial is testing

Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants

Who this might be right for
Graft Versus Host DiseaseBone Marrow Transplantation
University Health Network, Toronto 78
Testing effectiveness (Phase 2)WithdrawnNCT06297629
What this trial is testing

A Phase I/II Trial to Assess the Efficacy and Toxicity of ASTX727 (Oral Decitabine/Cedazuridine) for the Treatment of Hematological Neoplasms After Allogeneic Stem Cell Transplantation

Who this might be right for
Allogeneic Stem Cell Transplantation
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01700673
What this trial is testing

Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Large-scale testing (Phase 3)Study completedNCT01539083
What this trial is testing

Velcade (Bortezomib) Consolidation After Transplant

Who this might be right for
Multiple Myeloma
Janssen Scientific Affairs, LLC 256
Testing effectiveness (Phase 2)Study completedNCT04926194
What this trial is testing

Decidual Stromal Cells to Treat Graft-vs-Host Disease After Stem Cell Transplant for Myelodysplastic Syndrome/Myeloproliferative Neoplasm

Who this might be right for
Myelodysplastic/Myeloproliferative NeoplasmSteroid Refractory GVHDAllogeneic Hematopoietic Cell Transplant
University Health Network, Toronto 1
Testing effectiveness (Phase 2)Looking for participantsNCT06461988
What this trial is testing

Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma

Who this might be right for
Multiple MyelomaPost Stem Cell Transplant
Stanford University 20
Testing effectiveness (Phase 2)UnknownNCT03437603
What this trial is testing

Eltrombopag For Secondary Poor Graft Function Post Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Poor Graft Function
The First Affiliated Hospital of Soochow University 20
Testing effectiveness (Phase 2)Study completedNCT01529827
What this trial is testing

Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more
Roswell Park Cancer Institute 94
Not applicableUnknownNCT02172365
What this trial is testing

Allogeneic SCT for CML, TKI Failure After TKI Failure

Who this might be right for
Chronic Myeloid Leukemia
University Health Network, Toronto 350
Not applicableNo Longer AvailableNCT01945619
What this trial is testing

Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)

Who this might be right for
EBV InfectionCMV InfectionAdenoviral Infection
Baylor College of Medicine
Next Page